LymeNet Europe

Just frequently the most likely mechanism.

As long as you're ok with it when patients have evidence.

Yes, let's see how the Fallon thing plays out. At least there are efforts underway to mitigate the short-comings of standard conventional therapies. Patients before dogma, yes?

Which is why, I suspect, Fallon is running a study about this particular agent. It's called Science.

Far better than taking all those symptoms in all those late stage Lyme patients and labeling them MUS, then invoking the psych brigade to host a seance in the hopes the ghost of Freud might show.

A travesty, as it stands. Tens of thousands of Lyme patients potentially thrown under the bus. Slyly suggesting the MUS label to many who likely would be unfamiliar with the implications.

The downstream import to Europe could be frightening as well.

Thank you, X-member, for the tireless work you do.

I suspect part of the answer lies in testing tissue.

http://www.mdpi.com/2227-9032/6/2/33

A thoroughly enjoyable read, LymeBasics. Thank you.

Modifying or changing accepted definitions - or creating altogether new ones - to suit research ends is a dicey thing. It can backfire. Of course, this would be nothing new in the Lyme realm. Categorizing late manifestations of the disease into major and minor symptoms comes to mind, and I think tha...

You are incorrect in at least part of your claims. Even the IDSA will only commit to a "majority" of patients are cured, but as you well know studies range from up to 5% to up to 20% - and some higher - of patients will not be cured. As for seropositivity, go take a quick read of your IDSA manual. L...